Listar Artículos científicos por autor "Perez-Lloret, Santiago"
Mostrando ítems 1-8 de 8
-
Article
Disproportionality analysis of adverse neurological and psychiatric reactions with the ChAdOx1 (Oxford-AstraZeneca) and BNT162b2 (Pfizer-BioNTech) COVID-19 vaccines in the United Kingdom (2024)
Otero-Losada, Matilde; Petrovsky, Nikolai; Alami, Abdallah; Crispo, James A.; Mattison, Donald; Capani, Francisco; Goetz, Christopher; Krewski, Daniel; Perez-Lloret, Santiago (Taylor and Francis Ltd., 2023)Background: Information on neurological and psychiatric adverse events following immunization (AEFIs) with COVID-19 vaccines is limited. Research design & methods: We examined and compared neurological and psychiatric AEFIS ... -
Article
Editorial: Neuroprotection and disease modification in Parkinson’s disease: Volume II (2023)
Otero-Losada, Matilde; Gubellini, Paolo; Capani, Francisco; Perez-Lloret, Santiago (Frontiers Media S.A., 2023-01-09) -
Article
Effects of angiotensin type 1 receptor antagonists on Parkinson's disease progression: An exploratory study in the PPMI database (2021)
Udovin, Lucas Daniel; Otero-Losada, Matilde; Bordet, Sofia; Chevalier, Guenson; Quarracino, Cecilia; Capani, Francisco; Perez-Lloret, Santiago (Elsevier Ltd, 2021-05)Introduction: We explored the potential clinical effects of angiotensin-II AT1 receptor blockers (ARBs) and angiotensin-converting enzyme inhibitors (ACEIs) in patients from the Parkinson's Progress Marker Initiative (PPMI) ... -
Article
Genetics of Neurogenic Orthostatic Hypotension in Parkinson’s Disease, Results from a Cross-Sectional In Silico Study (2024)
Chevalier, Guenson; Udovin, Lucas; Otero-Losada, Matilde; Bordet, Sofia; Capani, Francisco; Luo, Sheng; Goetz, Christopher G.; Perez-Lloret, Santiago (MDPI, 2023)The genetic basis of Neurogenic Orthostatic Hypotension (NOH) in Parkinson’s disease (PD) has been inadequately explored. In a cross-sectional study, we examined the association between NOH and PD-related single-nucleotide ... -
Article
Neuroprotection from protein misfolding in cerebral hypoperfusion concurrent with metabolic syndrome. A translational perspective (2024)
Bordet, Sofía; Luaces, Juan Pablo; Herrera, Maria Ines; Gonzalez, Liliana Mirta; Kobiec, Tamara; Perez-Lloret, Santiago; Otero-Losada, Matilde; Capani, Francisco (Frontiers Media SA, 2023)Based on clinical and experimental evidence, metabolic syndrome (MetS) and type 2 diabetes (T2D) are considered risk factors for chronic cerebral hypoperfusion (CCH) and neurodegeneration. Scientific evidence suggests that ... -
Article
Parkinson's Disease in the Era of a Novel Respiratory Virus Pandemic (2020)
Otero-Losada, Matilde; Kobiec, Tamara; Udovin, Lucas Daniel; Chevalier, Guenson; Quarracino, Cecilia; Menéndez Maissonave, Camila; Bordet, Sofia; Capani, Francisco; Perez-Lloret, Santiago (Frontiers Media S.A., 2020-09-11) -
Article
The Genetic Basis of Probable REM Sleep Behavior Disorder in Parkinson’s Disease (2024)
Perez-Lloret, Santiago; Chevalier, Guenson; Bordet, Sofia; Barbar, Hanny; Capani, Francisco; Udovin, Lucas; Otero-Losada, Matilde (Multidisciplinary Digital Publishing Institute (MDPI), 2023)Patients with Parkinson’s Disease (PD) experience REM sleep behavior disorder (RBD) more frequently than healthy controls. RBD is associated with torpid disease evolution. To test the hypothesis that differential genetic ... -
Article
The Renin–Angiotensin System Modulates Dopaminergic Neurotransmission: A New Player on the Scene (2021)
Kobiec, Tamara; Otero-Losada, Matilde; Chevalier, Guenson; Udovin, Lucas Daniel; Bordet, Sofía; Menéndez-Maissonave, Camila; Capani, Francisco; Perez-Lloret, Santiago (Frontiers Media S.A., 2021-04-22)Parkinson’s disease (PD) is an extrapyramidal disorder characterized by neuronal degeneration in several regions of the peripheral and central nervous systems. It is the second most frequent neurodegenerative disease after ...